Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 2
2005 1
2006 2
2007 2
2008 3
2009 4
2010 6
2011 2
2012 1
2014 3
2015 3
2016 2
2018 3
2019 4
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease.
Ettcheto M, Busquets O, Cano A, Sánchez-Lopez E, Manzine PR, Espinosa-Jimenez T, Verdaguer E, Sureda FX, Olloquequi J, Castro-Torres RD, Auladell C, Folch J, Casadesús G, Camins A. Ettcheto M, et al. Among authors: sureda fx. J Alzheimers Dis. 2021;82(s1):S91-S107. doi: 10.3233/JAD-201106. J Alzheimers Dis. 2021. PMID: 33325386 Free PMC article. Review.
Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer's disease.
Camins A, Ettcheto M, Busquets O, Manzine PR, Castro-Torres RD, Beas-Zarate C, Verdaguer E, Sureda FX, Bulló M, Olloquequi J, Auladell C, Folch J. Camins A, et al. Among authors: sureda fx. Expert Opin Investig Drugs. 2019 Jan;28(1):93-97. doi: 10.1080/13543784.2019.1552677. Epub 2018 Dec 1. Expert Opin Investig Drugs. 2019. PMID: 30480461 No abstract available.
Role of c-Jun N-Terminal Kinases (JNKs) in Epilepsy and Metabolic Cognitive Impairment.
Busquets O, Ettcheto M, Cano A, R Manzine P, Sánchez-Lopez E, Espinosa-Jiménez T, Verdaguer E, Dario Castro-Torres R, Beas-Zarate C, X Sureda F, Olloquequi J, Auladell C, Folch J, Camins A. Busquets O, et al. Among authors: x sureda f. Int J Mol Sci. 2019 Dec 30;21(1):255. doi: 10.3390/ijms21010255. Int J Mol Sci. 2019. PMID: 31905931 Free PMC article. Review.
Sirtuin activators: designing molecules to extend life span.
Camins A, Sureda FX, Junyent F, Verdaguer E, Folch J, Pelegri C, Vilaplana J, Beas-Zarate C, Pallàs M. Camins A, et al. Among authors: sureda fx. Biochim Biophys Acta. 2010 Oct-Dec;1799(10-12):740-9. doi: 10.1016/j.bbagrm.2010.06.005. Epub 2010 Jun 23. Biochim Biophys Acta. 2010. PMID: 20601277 Review.
The NMDA receptor: beyond anaesthetic action.
Sureda FX, Mallol J. Sureda FX, et al. Adv Exp Med Biol. 2003;523:191-200. doi: 10.1007/978-1-4419-9192-8_17. Adv Exp Med Biol. 2003. PMID: 15088851 Review. No abstract available.
Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease.
Turcu AL, Companys-Alemany J, Phillips MB, Patel DS, Griñán-Ferré C, Loza MI, Brea JM, Pérez B, Soto D, Sureda FX, Kurnikova MG, Johnson JW, Pallàs M, Vázquez S. Turcu AL, et al. Among authors: sureda fx. Eur J Med Chem. 2022 Jun 5;236:114354. doi: 10.1016/j.ejmech.2022.114354. Epub 2022 Apr 8. Eur J Med Chem. 2022. PMID: 35453065 Free PMC article.
41 results